What are patient preferences for follow-up after low-grade cervical intraepithelial neoplasia?

Journal of Lower Genital Tract Disease

Volumn 12, Issue 2, 2008, Pages 122-126

  Patel, Minita ^a,b   Guido, Richard ^a   Chang, Judy C ^a   Meyn, Leslie A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE   (United States)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; Papanicolaon (Pap) smear testing

Indexed keywords

ADULT; ARTICLE; BIVARIATE ANALYSIS; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CENTER; HEALTH SERVICE; HEALTH SURVEY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; PAPANICOLAOU TEST; PATIENT REFERRAL; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS;

EID: 41449102596     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wright TC, Cox T, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 ASCCP-sponsored Consensus Workshop. 2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia. Am J Obstet Gynecol 2003;189:295-304.
2. Guido R, Schiffman M, Solomon D, Burke L, ASCUS LSILTriage Study (ALTS) Group. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: A two year prospective study. Am J Obstet Gynecol 2003;188:1401-5.
3. Hartz LE, Fenaughty AM. Management choice and adherence to follow up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet Gynecol 2001;98:674-9.
4. Kahn JA, Goodman E, Slap GB, Huang B, Emans SJ. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic. Obstet Gynecol 2003;101:490-9.
5. Pruitt SL, Parker PA, Peterson SK, Le T, Follen M, Basen-Engquist K. Knowledge of cervical dysplasia and human papillomavirus among women seen in a colposcopy clinic. Gynecol Oncol 2005;99:S236-44.
6. Massad LS, Verhulst SJ, Hagemeyer M, Brady P. Knowledge of the cervical cancer screening process among rural and urban Illinois women undergoing colposcopy. J Low Genit Tract Dis 2006;10:252-5.
7. Tiro JA, Meissner HI, Kobrin S, Chollette V. What do women in the US know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev 2007;16:288-94.
8. Waller J, McCaffery K, Wardle J. Beliefs about the risk factors for cervical cancer in a British population sample. Prev Med 2004;38:745-53.
9. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004;328:1293-9.
10. Idestrom M, Milsom I, Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand 2003;82:756-61.
11. Le T, Hicks W, Menard C, Boyd D, Hewson T, Hopkins L, et al. Human papilloma virus testing and knowledge and attitudes among women attending colposcopy clinic with ASCUS/LSIL pap smears. J Obstet Gynaecol Can 2004;26:788-92.
12. Philips Z, Avis M, Whynes DK. Introducing HPV triage into the English cervical cancer screening program: consequences for participation. Women Health 2006;43:17-34.
13. Benning BR, Lund MR. Patient knowledge about human papillomavirus and relationship to history of abnormal Papanicolaou test results. J Low Genit Tract Dis 2007;11:29-34.
14. Giles M, Garland S. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol 2006;46:311-5.